Abstract
The enkephalins can be cleaved by a variety of peptidases but it increasingly appears that two enzyme activities are mainly, if not solely, involved in their physiological inactivation (for reviews see Schwartz et al., 1981, 1982, 1983; Hui & Lajtha, 1983; Schwartz, 1983). The first, responsible for the cleavage of the Gly3-Phe4 amide bond of the opioid pentapeptides, is generally termed ‘enkephalinase’ (Malfroy et al., 1978). It is primarily associated with synaptic membranes (De La Baume et al., 1980) and is potently and selectively inhibited by Thiorphan® (Roques et al., 1980). Its inhibition allows an increased recovery of enkephalins released from striatal slices and, in vivo, a diminished responsiveness to various nociceptive stimuli (Patey et al., 1981; De La Baume et al., 1983; Chaillet et al., 1983a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ALGERI, S., ALTSTEIN, M., DE SIMONE, G.M. and GUARDABASSO, V. (1981). In vivo potentiation of (D-Ala2)met-enkephalin amide central effects after administration of an enkephalinase inhibitor. Eur. J. Pharmac., 74, 261–262.
ALMENOFF, J., WILS, S. and ORLOWSKI, M. (1981). Membrane bound pituitary metallo-endopeptidase: apparent identity to enkephalinase. Biochem. biophys. Res. Commun., 102, 206–214.
ALTSTEIN, M., BLUMBERG, S. and VOGEL, Z. (1982). Phosphoryl-Leu-Phe: A potent inhibitor of the degradation of enkephalin by enkephalinase. Eur. J. Pharmac., 76, 299–300.
BEN NATAN, L., CHAILLET, P., LECOMTE, J-M., MARCAIS-COLLADO, H., HUCHIDA, G. and COSTENTIN, J. (1984). Involvement of endogenous enkephalins in the mouse ‘behavioral despair’ test. Eur. J. Pharmac., 97, 301.
BÜNNING, P., HOLMQUIST, B. and RIORDAN, J.F. (1983). Substrate specificity and kinetic characteristics of angiotensin converting enzyme. Biochemistry, 22, 103–116.
CHAILLET, P., MARCAIS-COLLADO, H., COSTENTIN, J., YI, C.C., DE LA BAUME, S. and SCHWARTZ, J-C. (1983a). Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. Eur. J. Pharmac., 86, 329–336.
CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1983b). Catatonic or hypotonic immobility induced in mice by intracerebroventricular injections of mu and kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradation. Life Sci., 33, 2105–2111.
CHIPKIN, R.E., IORIO, L.C., BARNETT, A., BERGER, J. and BILLARD, W. (1982). In Regulatory Peptides: From Molecular Biology to Function. Costa, E. and Trabucchi, M. (eds) pp.235–242, New York: Raven Press.
DE LA BAUME, S., PATEY, G. and SCHWARTZ, J-C. (1980). Subcellular distribution of enkephalin dipeptidylcarboxypeptidase (‘enkephalinase’) in rat brain. Neuroscience, 6, 315–321.
DE LA BAUME, S., YI, C.C., SCHWARTZ, J-C., CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1983). Participation of both ‘enkephalinase’ and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience, 8, 143–151.
DESCHODT-LANCKMAN, M. and STROSBERG, D. (1983). In vitro degradation of the C-terminal octapeptide of cholecystokinin by enkephalinase A. FEBS Lett., 152, 109–113.
ERDÖS, E.G., JOHNSON, A.R. and BOYDEN, N.T. (1978). Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem. Pharmac., 27, 843–848.
FLORAS, P., BIDABÉ, A.M., CAILLÉ, J-M., SIMONNET, G., LECOMTE, J-M., & SABATHIE, M. (1983). Double-blind study of effects of enkephalinase inhibitor on adverse reactions to myelography. Am. J. Neuroradiology, 4, 653–655.
FULCHER, I.S., MATSAS, R., TURNER, A.J. and KENNY, A.J. (1982). Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membrane show similar sensitivity to inhibitors. Biochem. J., 203, 519–522.
HERSH, L.B. (1981). Solubilization and characterization of two rat brain membrane-bound aminopeptidases active on Met-enkephalin. Biochemistry, 20, 2345–2350.
HUDGIN, R.L., CHARLESON, S.E., ZIMMERMAN, M., MUMFORD, R. and WOOD P.L. (1981). Enkephalinase: selective peptide inhibitors. Life Sci., 29, 2593–2601.
HUI, K.S. and LAJTHA, A. (1983). In Handbook of Neurochemistry. Lajtha, E. (ed.) pp.1–19, New York: Plenum Publishing Corp.
HUI, K.S., WANG, Y.J. and LAJTHA, A. (1983). Purification and characterization of an enkephalin aminopeptidase from rat brain membranes. Biochemistry, 22, 1062–1067.
INOKUCHI, J.I. and NAGAMATSU, A. (1981). Tripeptidyl carboxypeptidase activity of kininase II (angiotensin converting enzyme). Biochem. biophys. Res. Commun., 662, 300–307.
KAYSER, V. and GUILBAUD, G. (1983). The analgesic effects of morphine but not those of the enkephalinase inhibitor, Thiorphan, are enhanced in arthritic rats. Brain Res., 267, 131–138.
KENNY, A.J. (1977). In Proteinases in mammalian cells and tissues. Barrett, A.J. (ed.) pp. 393–444, Amsterdam: North-Holland.
KORF, J., BUNNEY, B.S. and AGHAJANIAN, G.K. (1974). Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmac., 25, 165–169.
LLORENS, C., GACEL, G., SWERTS, J-P., PERDRISOT, R., FOURNIE-ZALUSKI, M.C., SCHWARTZ, J-C. and ROQUES, B.P. (1980). Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides. Biochem. biophys. Res. Commun., 96, 1710–1717.
LLORENS, C., MARTRES, M-P., BAUDRY, M. and SCHWARTZ, J-C. (1978). Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependance. Nature, 274, 603–605.
LLORENS, C. and SCHWARTZ, J-C. (1984). Changes in turnover of cerebral monoamine following inhibition of enkephalin metabolism by Thiorphan and Bestatin. Eur. J. Pharmac. (in press).
MALFROY, B. and SCHWARTZ, J-C. (1982). Properties of ‘enkephalinase’ from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities. Biochem. biophys. Res. Commun., 106, 276–285.
MALFROY, B., SWERTS, J-P., GUYON, A., ROQUES, B.P. and SCHWARTZ, J-C. (1978). High affinity enkephalindegrading peptidase in brain is increased after morphine. Nature, 276, 523–526.
MALFROY, B., SWERTS, J-P., LLORENS, C. and SCHWARTZ, J-C. (1979). Regional distribution of a high-affinity enkephalin-degrading peptidase (‘enkephalinase’) and effects of lesions suggest localization in the vicinity of opiate receptors in brain. Neurosci. Lett., 11, 329–334.
MATSAS, R., FULCHER, I.S., KENNY, A.J. and TURNER, A.J. (1983). Substance P and (Leu) enkephalin are hydrolysed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. natn. Acad. Sci. U.S.A., 80, 3111–3115.
MONTEL, H., STARKE, K. and WEBER, F. (1974). Influence of morphine and naloxone on the release of NA from brain cortex slices. Naunyn-Schmiedebergs Arch. Pharmac., 283, 357–359.
MUMFORD, R.A., ZIMMERMAN, M., BROEKE, J.T., TAUB, D., JOSHUA, H., ROTHROCK, S.W., HIRSHFIELD, J.M., SPRINGER, J.P. and PATCHETT, A.A. (1982). Inhibition of porcine kidney ‘enkephalinase’ by substituted-D-carboxymethyl dipeptides. Biochem. biophys. Res. Commun., 109, 1303–1309.
PATEY, G., DE LA BAUME, S., SCHWARTZ, J-C., GROS, C., ROQUES, B.P., FOURNIE-ZALUSKI, M.C. and SOROCALUCAS, E. (1981). Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science, 212, 1153–1155.
ROQUES, B.P., FOURNIE-ZALUSKI, M.C., SOROCA, E., LECOMTE, J-M., MALFROY, B. and SCHWARTZ, J-C. (1980). The enkephalinase inhibitor. Thiorphan shows antinociceptive activity in mice. Nature, 288, 286–288.
SCHWARTZ, J-C. (1983). Metabolism of enkephalins and the concept of neuropeptidase. Trends Neurosci., 6, 15–18.
SCHWARTZ, J-C., DE LA BAUME, S., YI, C.C., CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1982). Enkephalin metabolism in brain and its inhibition. Prog. Neuro. Psych., 6, 665–671.
SCHWARTZ, J-C., DE LA BAUME, S., YI, C.C., CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1983). Peptidases involved in the inactivation of exogenous and endogenous enkephalins. J. Neural trans., 18, 235–243.
SCHWARTZ, J-C., GROS, C., GIROS, B., LLORENS, C., MALFROY, B., ROSE, C. and ZUZEL, K. (1984). Metabolic inactivation of enkephalins. Proceedings of the 5th Meeting of the Eur. Soc. Neurochem. Amsterdam: Elsevier Publishers (in press).
SCHWARTZ, J-C., MALFROY, B. and DE LA BAUME, S. (1981). Biological inactivation of enkephalins and the role of enkephalin dipeptidyl carboxypeptidase (‘enkephalinase’) as neuropeptidase. Life Sci., 29, 1715–1740.
SCHWARTZ, J-C., POLLARD, H., LLORENS, C., MALFROY, B., GROS, C., PRADELLES, P. and DRAY, F. (1978). In Advances in biochemical psychopharmacology. Costa, E. and Trabucchi, M. (eds) pp. 245–264, New York: Raven Press.
UMEZAWA, H., AOYAGI, T., SUDA, H., HAMADA, M. and TAKEUCHI, T. (1976). Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiotics, 29, 97–99.
WOOD, P.L. (1982). Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitors. Eur. J. Pharmac., 82, 119–120.
YAKSH, T.L. and HARTY, G.M. (1982). Effects of thiorphan on the antinociceptive actions of intrathecal (DA1a2, Met5) enkephalin. Eur. J. Pharmac., 79, 293–300.
ZHANG, A.Z., YANG, H.Y.T. and COSTA, E. (1982). Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors. Neuropharmacology, 21, 625–630.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1984 Macmillan Publishers Limited
About this chapter
Cite this chapter
Schwartz, J.C., Giros, B., Gros, C., Llorens, C., Malfroy, B. (1984). Metabolism of enkephalins and its inhibition. In: Paton, W., Mitchell, J., Turner, P., Padgham, C., Ashcroft, E. (eds) IUPHAR 9th International Congress of Pharmacology London 1984. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-17615-1_40
Download citation
DOI: https://doi.org/10.1007/978-1-349-17615-1_40
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-0-333-37136-7
Online ISBN: 978-1-349-17615-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)